After validating the beneficial effects of the sEHi UB‐SCG‐51, our next goal was to go deeper into the molecular pathways implicated in the beneficial effects of sEH inhibition in an AD mice model with an RNA‐seq approach. This evidence concerns the gene EPHX2 and Alzheimer disease.